4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Jasper Therapeutics, Inc. (JSPR) operates in the Biotechnology industry and is headquartered in Redwood City, United States. Its market capitalization is roughly $18 million. In the fiscal year ended 2025-12-31, JSPR reported $0M in revenue and ($76M) in net income.
Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($84M) | ($76M) | ($69M) | ($51M) | — |
| Net Income | ($76M) | ($71M) | ($64M) | ($38M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($9M) | ($11M) | ($16M) | ($19M) | ($27M) | — |
| Net Income | ($3M) | ($1M) | ($9M) | ($19M) | ($27M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $36M | $80M | $95M | $48M | — |
| Total Liabilities | $32M | $18M | $16M | $12M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive JSPR viewer.
About TickerBase · Data methodology & sources · Privacy · Terms